One of the major failures of addressing the COVID19 pandemic is the breakdown of testing. The NFL and White House were able to maintain business as usual because of daily, accurate testing. When the disease is detected, its spread can be controlled. Jo Bhakdi of Quantgene talks about testing and how his company has scaled up testing solutions to at least apply them commercially to businesses wishing to maintain operations and protect their employees. We talk about testing and how it may be scaled to a national level. In the second half we talk about early cancer detection in a blood draw, an exciting possibility that would save lives and money through the earliest possible detection of several major cancers. Website: https://chooseserenity.com/covid Facebook: https://www.facebook.com/SameDayCOVIDTestinghttps://www.instagram.com/choose_serenity/https://twitter.com/quantgene Instagram: https://www.instagram.com/choose_serenity/ Twitter: https://www.instagram.com/choose_serenity/https://twitter.com/quantgene # COLABRA Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/ # TALKING BIOTECH Twitter: https://twitter.com/talkingbiotech Website: https://www.colabra.app/podcasts/talking-biotech/ Instagram: https://www.instagram.com/colabrahq The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.